title: Results of unrelated umbilical cord blood hematopoietic stem cell transplantation.
abstract: The number of umbilical cord blood transplants is increasing worldwide. The purpose of Eurocord is to evaluate the results and to compare the outcome of umbilical cord blood transplants with allogeneic bone marrow transplants. Data have been reported to Eurocord by multiple transplant centers. Close links have been established with the cord blood banks through Netcord. Bone marrow transplant data have been provided by transplant centers and also through the European Group for Blood and Marrow Transplantation (EBMT) and International Bone Marrow Transplant Registries (IBMTR). Eurocord has analyzed the outcome of unrelated umbilical cord blood transplants from 121 transplant centers and 29 countries. The results showed that survival with unrelated mismatched umbilical cord blood transplants was comparable to that with unrelated bone marrow transplants. Engraftment with cord blood was delayed, resulting in an increased incidence of early transplant complications. The incidence of acute and chronic graft-vs.-host disease was reduced with cord blood grafts even in human leukocyte antigen (HLA)-mismatched transplants and in adults. In patients with leukemia, the rate of relapse was similar to the rate of relapse after bone marrow transplant. The overall event-free survival with umbilical cord blood transplantation was not statistically different when compared to bone marrow transplants. This large registry study confirms the potential benefit of using umbilical cord blood hematopoietic stem cells for allogeneic transplants.
authors.affiliation: Eurocord Hematology Bone Marrow Transplant and Biostatistics Departments, Hospital Saint Louis, Paris, France. eliane.gluckman@sls.aphop-paris.fr
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: V
authors.initials: V
authors.lastname: Rocha
authors.forename: S
authors.initials: S
authors.lastname: Chevret
mesh_terms: D005312:Fetal Blood / Q000166:cytology*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods / Q000592:standards*; D006648:Histocompatibility; D006801:Humans; D014184:Transplantation, Homologous / Q000592:standards; D016896:Treatment Outcome